SPARC and neoplasm: We hypothesize that in luminal tumors, genetic variants may alter the function of certain proteins expressed intracellularly or in the tumor microenvironment, such as SPARC, and, consequently, may prevent the effects of standard chemotherapy treatment on the tumor cells, leading to a worse prognosis [48,49,50,51,52].